Kestra Investment Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.43M Buy
6,708
+2,256
+51% +$772K 0.05% 121
2026
Q1
$1.57M Sell
4,452
-2,407
-35% -$858K 0.03% 159
2025
Q4
$2.25M Sell
6,859
-545
-7% -$173K 0.05% 127
2025
Q3
$2.09M Buy
7,404
+503
+7% +$146K 0.06% 122
2025
Q2
$1.93M Buy
6,901
+418
+6% +$118K 0.06% 118
2025
Q1
$2.02M Buy
6,483
+2,905
+81% +$858K 0.06% 97
2024
Q4
$933K Buy
3,578
+147
+4% +$43.6K 0.04% 145
2024
Q3
$1.11M Buy
+3,431
New +$1.12M 0.05% 111

Other funds holding AMGN

Kestra Investment Management's AMGN Position: Q2 2026 in Review

Kestra Investment Management increased its Amgen (AMGN) stake by 51% in Q2 2026, buying an estimated $772K and bringing the position to 6,708 shares worth $2.43M. The position accounts for 0.05% of the portfolio, ranked #121.

Kestra Investment Management first reported a position in AMGN in Q3 2024 and has held it in 8 quarters since. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Kestra Investment Management held 6,708 shares of Amgen worth $2.43M as of Q2 2026.
  • Kestra Investment Management bought 2,256 Amgen shares in Q2 2026, an estimated $772K.
  • Amgen made up 0.05% of Kestra Investment Management's portfolio in Q2 2026, its #121 holding.
  • Kestra Investment Management first reported a position in Amgen in Q3 2024 and has held it in 8 quarters since.
  • 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Kestra Investment Management's 13F filing for Q2 2026, filed 5 Aug 2026.